The present invention relates to inhibitors of 11-² hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-² hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess.
申请公布号
EP2450351(A1)
申请公布日期
2012.05.09
申请号
EP20120153931
申请日期
2005.11.09
申请人
INCYTE CORPORATION
发明人
YAO, WENQING;HE, CHUNHONG;ZHUO, JINCONG;XU, MEIZHONG;ZHANG, COLIN;QIAN, DING-QUAN;BURNS, DAVID;METCALF, BRIAN, W.